Showing 821 - 840 results of 107,962 for search '(( a de decrease ) OR ( 5 ((((mean decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 1.59s Refine Results
  1. 821
  2. 822
  3. 823
  4. 824
  5. 825
  6. 826
  7. 827
  8. 828
  9. 829
  10. 830
  11. 831
  12. 832

    BA decreases DUB activity in PC cells. by Teresita Reiner (281437)

    Published 2013
    “…(<b>B</b>) DUB assay showed that BA treatment of LNCaP cells significantly decreased DUB activity at 24 and 48 h relative to control treated cells ( = 1) (*, <i>P</i><5×10<sup>−5</sup>). …”
  13. 833

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
  14. 834
  15. 835
  16. 836
  17. 837

    Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

    Published 2012
    “…Representative FACS staining is shown including quantification (n = 4–5 mice per group). (E) Laquinimod decreases pathogenic potential of T cells. …”
  18. 838

    Decreased TNIP1 expression in SSc patients. by Yannick Allanore (58641)

    Published 2011
    “…(B) Consistent with these findings, a 1.7-fold decrease of <i>TNIP1</i> mRNA levels was observed in dermal fibroblasts from SSc patients (* indicates a <i>P</i>-value = 0.001 <i>vs.…”
  19. 839

    Dopamine decreases the refractive power in the lens periphery. by J. Marcus Schartau (365288)

    Published 2013
    “…<p>(A) The mean ΔBCD curves describe the difference between the treated and untreated lenses from all animals (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0010402#s4" target="_blank">Methods and Materials</a>). …”
  20. 840